Spyre Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC SYRE

Report date

3/31/2022

Quarter

2022 Q1

Filed

5/13/2022

Shares

106,810

Value ($000)

246

Weight

0.0%

2019 Q4 - 2022 Q1 (10 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q1	5/13/2022	246	0.0%	106,810	3/31/2022
2021 Q4	2/11/2022	473	0.0%	99,477	12/31/2021
2021 Q3	11/16/2021	791	0.0%	99,477	9/30/2021
2021 Q2	8/16/2021	737	0.0%	105,779	6/30/2021
2021 Q1	5/17/2021	878	0.0%	110,783	3/31/2021
2020 Q4	2/16/2021	885	0.0%	112,424	12/31/2020
2020 Q3	11/13/2020	750	0.0%	105,653	9/30/2020
2020 Q2	8/20/2020	1,007	0.0%	108,846	6/30/2020
2020 Q1	5/15/2020	283	0.0%	60,560	3/31/2020
2019 Q4	2/7/2020	456	0.0%	59,621	12/31/2019